Early Development Strategy Lead (APAC)

Shanghai, China Full time
Notify me about similar jobs

Ipsen (shanghai) innovation pharmaceutical Co., Ltd. is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

Title:

Early Development Strategy Lead (APAC)

Company:

Ipsen (shanghai) innovation pharmaceutical Co., Ltd.

About Ipsen:

Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

For more information, visit us at https://www.ipsen.com/   and follow our latest news on LinkedIn and Instagram .

Job Description:

To serve as the regional subject matter expert in Early Development (Phase I / First-in-Human / Proof-of-Concept / Basket trials) for the APAC region, providing deep scientific and operational intelligence to inform global and regional trial design and execution strategies. A focus of the position will be Oncology.

Where appropriate, to optimise relationships with CRO partners and country level clinical sites, all whilst ensuring accelerated and high-quality execution of Ipsen-sponsored Early Development clinical trials

Accountable for delivery of Global and Regional (APAC ) Early Development clinical trials to facilitate successful regulatory submissions by ensuring data integrity, inspection readiness and to maintain alignment with global development strategy.

To optimize the country contribution to early clinical programs, Global and Regional,  through proactive operational leadership, KOL engagement, and effective cross-functional collaboration.

To act as the strategic bridge between Global Early Development teams and the APAC site/investigator landscape, ensuring that protocol design, feasibility, and site selection are informed by the most current, on-the-ground intelligence and relationships with Phase I units across the region.

To build the APAC Region Early Development operations skills through effective recruitment and staff development and through a mindset of continuous improvement and innovation.  Optimise the FSP organizational structure in support of Early Development strategy and clinical studies across APAC.

Main Responsibilities & Technical Competencies

Early Development Site Network Relationship Management

Develop a regional network of preferred sites in Early Development and optimize the relationships with these sites to ensure that IPSEN is seen as a partner of choice in Early Development

Support dissemination of approved clinical trial–related information to investigators (in coordination with Medical Affairs in the APAC region)

Be the Primary IPSEN Early Development contact for Country and Regional KOLs across APAC

Develop and execute KOL engagement strategies to support clinical trial success and strengthen the APAC regions positioning within global Early development programs.

Strategic Design and Study Input

Be the Regional CDO Early Development representative within Global Study Teams, ensuring alignment between global clinical strategy and local operational execution

To be the APAC region expert in Clinical Operations  with a focus on Early Development and to provide proactive strategic input to Global Operations regarding  country specific regulatory, operational, enrollment, and Key Opinion Leader/Investigator landscape considerations.

Provide structured feedback from investigators and KOLs to Global teams, including insights on unmet needs, protocol feasibility, competitive intelligence.

Ensure intelligence is shared with Global Teams so that study start up, conduct and close out are informed by local country requirements and local barriers to delivery are mitigated

Collect and analyze all data to inform protocol development and operational plans related to pipeline delivery

Leads country/regional level escalation for operational risks impacting study timelines or regulatory milestones for local and global studies

Accountable to design and implement country/region specific acceleration strategies to shorten study start-up timelines and enhance patient enrollment while maintaining global standards and inspection readiness

Optimise feasibility assessment across APAC, site selection, contract execution, and IRB approval timelines in collaboration with CRO and internal stakeholders.

Capability Building

Develops expertise (self and in colleagues) in disease state management, emerging therapies, and the competitive landscape to optimize the country contribution to IPSEN Clinical Studies.  A focus will be the Oncology TA

Mentors and supports the  CRAs (FSP or Full service CRO) that are working on ED studies in APAC

Support upskilling of regional CRA teams (FSP or CRO-partnered) on early-development specific requirements, including basket trial conduct, patient identification strategies, and Phase I unit dynamics

Where necessary, oversees CRO performance to ensure delivery against timelines, budget, and quality standards; establish clear KPIs and drive corrective actions where needed

Regional Representation

Collaborate closely with country/Regional Medical Affairs to ensure appropriate site level information exchange while maintaining clear functional boundaries.

Support preparation of clinical and operational components of country regulatory packages in collaboration with Global Clinical and Regulatory teams.

Partner closely with Global Clinical Development, Regulatory, and other functions to ensure regional intelligence is incorporated into regulatory submissions, IND strategies, and site engagement plans.

Provide timely support for responses to regulatory queries related to clinical trial conduct and data interpretation

Represents IPSEN at appropriate national, regional, and international meetings in the relevant therapeutic area, serving to gather information on developments in the therapeutic area, and becomes a country ambassador

Quality and Continuous Improvement

Ensure protocol compliance, data integrity, and continuous inspection readiness at assigned clinical sites.

Responsible to drive performance improvement initiatives and a continuous improvement mindset in relation to Early Development studies

Contribute to inspection preparation activities and ensure all assigned trials remain audit-ready

Knowledge & Experience:

Knowledge & Experience:

Minimum 10 years of experience in Clinical Development/Operations within the pharmaceutical industry

Demonstrated Expertise in Early Development Programmes particularly Oncology

Demonstrated understanding of early-phase trial design, including basket, umbrella, and adaptive designs in oncology.

Demonstrated track record in selecting and building relationships with key Early Development Sites across APAC

Demonstrated CRO oversight and performance management experience.

Participation in Global Study Teams with demonstrated cross-regional  and cross functional collaboration experience.

Strong knowledge of Local/Global GCP requirements and inspection processes.

Proven experience in clinical trial start-up and enrollment management for local and Global studies

Experience supporting NMPA and/or other APAC regional regulatory submissions and query responses preferred.

Strong project management skills with ability to manage multiple priorities.

Excellent analytical, communication, and stakeholder management skills

Excellent communication and influencing skills, with the ability to work effectively across matrix teams without direct line authority over operational staff

Demonstrated ability to manage change and to implement an environment of continuous improvement and innovation

Education / Certifications :

A minimum of Bachelor of Science, post-graduate degree (or equivalent) in life sciences or related field is desirable.

Language(s) :

Fluent verbal and written communication skills in local language and English

We are committed to creating a workplace where everyone feels heard, valued, and supported; where we embrace “The Real Us”. The value we place on different perspectives and experiences drives our commitment to inclusion and equal opportunities. When we include diverse ways of thinking, we make more thoughtful decisions and discover more innovative solutions. Together we strive to better understand the communities we serve. This means we also want to help you perform at your best when applying for a role with us. If you require any adjustments or support during the application process, please let the recruitment team know. This information will be handled with care and will not affect the outcome of your application.

Job details

Seniority
Not listed
Function
BD&L & Strategic Planning
Therapeutic area
Not listed
Location
Shanghai, China
Employment type
Full time

How this role compares

Computed from every other active BD&L & Strategic Planning role in our database, not just this employer's listings.

We currently track 383 comparable BD&L & Strategic Planning roles across 84 biopharma companies.

383Comparable roles tracked
359Currently active
84Companies hiring similar roles
38Countries represented

Salary context

106 of 383 peers report a salary range (USD, annualized)

Peers share this role's job function. This posting doesn't list a seniority level, so peers aren't narrowed by seniority either -- the range below may span more levels than usual.

This roleSubject Not listed on this posting
Lowest disclosed · Senior Inside Business Development Manager · AbbVie $27/hr – $48/hr (≈ $56,160–$99,840/yr)
Peer group range $78,000 – $380,750 (median $205,000)

Where these roles are based

Top locations among the 383 comparable roles

United States182
China54
India15
Japan14
Switzerland14
Germany14

+ 32 more countries

Seniority mix

282 of 383 peers have a known seniority level

Director82
Manager82
Associate Director46
Senior Director26
Intern/Fellow/Postdoc17
Senior11
Principal7
Associate6
Executive/VP5

Therapeutic area mix

58 of 383 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology26
Immunology9
Neuroscience8
Dermatology & Aesthetics5
Respiratory3
Cardiovascular / CVRM3
Ophthalmology2
Rare Disease1
Vaccines & Infectious Disease1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

40%similar
Lilly Shanghai, Shanghai, China Senior Director
Same function Same country
40%similar
Gilead Sciences Shanghai Pharmaceutical Technology Co., Ltd. Shanghai, China Director
Same function Same country
40%similar
Pfizer Investment Co., Ltd. China Shanghai, China
Same function Same country
40%similar
Shenzhen Sanofi Biological Products Co., Ltd. Beijing, China Senior Director
Same function Same country
40%similar
Novartis Shanghai (Shanghai), China Director
Same function Same country
40%similar
Novartis Shanghai (Shanghai), China Director
Same function Same country

Notify me about similar jobs

Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.

Or follow a whole field: get every new BD&L & Strategic Planning job in China, and choose locations and companies.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

40%
Senior Director--External Innovation
Lilly · Shanghai, Shanghai, China · Senior Director
Function Therapeutic area Seniority Country
40%
Senior Director & Asia Pacific Regional Lead, External R&D
Shenzhen Sanofi Biological Products Co., Ltd. · Beijing, China · Senior Director
Function Therapeutic area Seniority Country
40%
Director, Alliance Management
Novartis · Shanghai (Shanghai), China · Director
Function Therapeutic area Seniority Country
40%
Director, Search & Evaluation
Novartis · Shanghai (Shanghai), China · Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.